Evidence map›Paper›PMID 41068326›Full record

ArticleCancer causes & control : CCC2025

Use of healthcare services and prescription medication prior to sarcoma diagnosis in children, adolescents, and young adults in 1997-2020: a population-based cohort study.

Daniel Thor Halberg Dybdal, Ólafur Birgir Davidsson, Signe Holst Søegaard, Michael Mørk Petersen, Ninna Aggerholm-Pedersen, Henrik Hjalgrim, Klaus Rostgaard, Lisa Lyngsie Hjalgrim

Abstract read
In one paragraph

Article in Cancer causes & control : CCC, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daniel Thor Halberg DybdalDanish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-5039-0367
Ólafur Birgir DavidssonDanish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-7226-5409
Signe Holst SøegaardDanish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-4857-7186
Michael Mørk PetersenDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-2324-6420
Ninna Aggerholm-PedersenDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark.ORCID http://orcid.org/0000-0002-6859-5296
Henrik HjalgrimDanish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-4436-6798
Klaus RostgaardDanish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-6220-9414
Lisa Lyngsie HjalgrimDepartment of Paediatric and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. lisa.lyngsie.hjalgrim@regionh.dk.ORCID http://orcid.org/0000-0001-5186-3365

Funding

Børnecancerfonden,Denmark 2021-7416 and 2022-8218Kræftens Bekæmpelse R367-A21533
6 · The paper itself

Abstract

purposeSarcomas are among the leading causes of cancer death in children, adolescents, and young adults and survival has not been substantially improved for decades. Reducing the diagnostic interval could contribute meaningfully to increased survival at a low- cost. This study provided much-needed knowledge of the prediagnostic patient trajectories to direct future clinical efforts.

methodsThis population-based study examined the use of healthcare services in the two years preceding diagnosis in 1524 children, adolescents, and young adults with sarcoma compared to the background population, based on Danish national register data from 1997 to 2020.

resultsSarcoma patients were more likely than the background population to have contacts in the primary healthcare sector, hospital outpatient clinics, and emergency rooms, and to fill prescriptions for pain- and antimicrobial medication for up to 24 consecutive months before diagnosis. Patients with metastatic sarcoma at the time of diagnosis were more likely than non-metastatic patients to use healthcare services in the last 2-4 months prior to diagnosis.

conclusionReducing the diagnostic interval in early-life sarcomas should be explored as a low-cost complement to new, advanced treatments to improve survival. Efforts should focus on improving the selection of CAYA with musculoskeletal symptoms for early referral and a better understanding of the diagnostic pathway within the secondary healthcare system.

Indexed as

Prescription DrugsSarcomaAdolescentAdultChildChild, PreschoolCohort StudiesDenmarkFemaleHumansInfantMaleRegistriesYoung AdultPrescription DrugsAdolescentsChildrenDiagnostic intervalSarcomaYoung adults

Identifiers

PMID41068326
PMCPMC12630154

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.